{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:15:56Z","timestamp":1788066956148,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154364","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:11:54Z","timestamp":1785337914000},"page":"154364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrated transcriptomic and functional analyses identify PRR7 as a therapeutic target that associated with Wnt\/\u03b2-catenin signaling and docetaxel resistance in prostate cancer"],"prefix":"10.1016","volume":"832","author":[{"given":"Wei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enlai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9657-0626","authenticated-orcid":false,"given":"Dongdong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154364_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.154364_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41585-022-00669-z","article-title":"Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?","volume":"20","author":"Chen","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbrc.2026.154364_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114392","article-title":"Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies","volume":"160","author":"Hashemi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.154364_bib4","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.08.011","article-title":"Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205","volume":"181","author":"Puhr","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2026.154364_bib5","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/1535-7163.MCT-13-0775","article-title":"Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer","volume":"13","author":"Marin-Aguilera","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrc.2026.154364_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100754","article-title":"Therapeutic strategies to overcome taxane resistance in cancer","volume":"55","author":"Das","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154364_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154364_bib8","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ccell.2024.08.005","article-title":"Cancer cell states: lessons from ten years of single-cell RNA-sequencing of human tumors","volume":"42","author":"Tirosh","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154364_bib9","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41388-024-03057-6","article-title":"Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer","volume":"43","author":"Zhao","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154364_bib10","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1245\/s10434-016-5354-5","article-title":"High absolute monocyte count predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy","volume":"23","author":"Shigeta","year":"2016","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.bbrc.2026.154364_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050773","article-title":"Tumor-associated macrophage promotes the survival of cancer cells upon docetaxel chemotherapy via the CSF1\/CSF1R-CXCL12\/CXCR4 axis in castration-resistant prostate cancer","volume":"12","author":"Guan","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbrc.2026.154364_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154364_bib13","first-page":"676","article-title":"Molecular mechanisms of docetaxel resistance in prostate cancer","volume":"3","author":"Sekino","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.bbrc.2026.154364_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157119","article-title":"Docetaxel resistance in breast cancer: current insights and future directions","volume":"26","author":"Postigo-Corrales","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154364_bib15","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/s41467-021-21884-z","article-title":"Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer","volume":"12","author":"Aissa","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154364_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s42003-025-07959-3","article-title":"Identification of drug-resistant individual cells within tumors by semi-supervised transfer learning from bulk to single-cell transcriptome","volume":"8","author":"Huang","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2026.154364_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.14348\/molcells.2021.0042","article-title":"Integrative multi-omics approaches in cancer research: from biological networks to clinical subtypes","volume":"44","author":"Heo","year":"2021","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbrc.2026.154364_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","article-title":"Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment","volume":"24","author":"Le","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154364_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40779-024-00526-7","article-title":"The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy","volume":"11","author":"Feng","year":"2024","journal-title":"Milit. Med. Res."},{"key":"10.1016\/j.bbrc.2026.154364_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41568-025-00824-9","article-title":"Cancer institute acquired resistance to therapy, acquired resistance in cancer: towards targeted therapeutic strategies","volume":"25","author":"Soragni","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154364_bib21","first-page":"252","article-title":"AZGP1P2\/UBA1\/RBM15 Cascade mediates the fate determinations of prostate cancer stem cells and promotes therapeutic effect of docetaxel in castration-resistant prostate cancer via TPM1 m6A modification","volume":"6","author":"Wang","year":"2023","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.bbrc.2026.154364_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101158","article-title":"Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation","volume":"77","author":"Gao","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154364_bib23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmet.2022.03.013","article-title":"The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function","volume":"34","author":"Wenes","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2026.154364_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00109-017-1531-7","article-title":"Stem cell-derived organoids and their application for medical research and patient treatment","volume":"95","author":"Bartfeld","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbrc.2026.154364_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217122","article-title":"Establishment of advanced tumor organoids with emerging innovative technologies","volume":"598","author":"Mao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154364_bib26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1242\/dev.140566","article-title":"Translational applications of adult stem cell-derived organoids","volume":"144","author":"Drost","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.bbrc.2026.154364_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-pharmtox-010818-021108","article-title":"Organoids for drug discovery and personalized medicine","volume":"59","author":"Takahashi","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2026.154364_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2026.154364_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154364_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/beta-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154364_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104794","article-title":"Targeting the beta-catenin signaling for cancer therapy","volume":"160","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.154364_bib32","first-page":"507","article-title":"Modulating beta-catenin homeostasis for cancer therapy","volume":"10","author":"Xu","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbrc.2026.154364_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","article-title":"Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers","volume":"142","author":"White","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.154364_bib34","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-018-05858-2","article-title":"Reciprocal control of excitatory synapse numbers by Wnt and Wnt inhibitor PRR7 secreted on exosomes","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:20:37Z","timestamp":1788063637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S0006291X26011289"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154364","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated transcriptomic and functional analyses identify PRR7 as a therapeutic target that associated with Wnt\/\u03b2-catenin signaling and docetaxel resistance in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154364"}}